Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Esophageal Cancer


Trastuzumab plus Trimodal Treatment for Esophageal Cancer (RTOG-1010)
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Investigator: Veena Shankaran, MD;   Conditions: Esophageal Cancer;    Status: Recruiting;   Study ID: NCT01196390

PET Scan Imaging for Patients with Esophageal Cancer (RTOG 1175)
Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer

Investigator: George Laramore, MD, PhD;   Conditions: Esophageal Cancer;    Status: Recruiting;   Study ID: NCT01333033

AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma (20140070)
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG 337 in Subjects with MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET

Investigator: Veena Shankaran;   Conditions: Gastric/Esophageal Adenocarcinoma;    Status: Recruiting;   Study ID: NCT02016534